News
TEVA
13.46
+4.99%
0.64
After Hours Most Active for Apr 9, 2025 : TSLL, NVDA, TQQQ, INTC, SQQQ, TSLA, TEVA, INFA, VRN, AZEK, NU, BHC
NASDAQ · 2d ago
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
Seeking Alpha · 2d ago
Teva Pharmaceutical Industries (NYSE:TEVA) Pops As FDA Expands AJOVY'S Use For Pediatric Migraine Prevention
Simply Wall St · 2d ago
Pharma, MedTech stocks bounce back as Trump pauses tariffs
Seeking Alpha · 2d ago
Teva put volume heavy and directionally bearish
TipRanks · 2d ago
Bristol-Myers gets Pomalyst antitrust case dismissed
Seeking Alpha · 2d ago
Teva, Samsung Bioepis launch biosimilar against AstraZeneca’s Soliris
Seeking Alpha · 4d ago
Teva, Samsung Bioepis announce EPYSQLI availability in the U.S.
TipRanks · 4d ago
Teva filing for label expansion of migraine therapy Ajovy undergoes FDA review
Seeking Alpha · 4d ago
TEVA AND SAMSUNG BIOEPIS ANNOUNCE BIOSIMILAR EPYSQLI® (ECULIZUMAB-AAGH) INJECTION NOW AVAILABLE IN THE UNITED STATES
Reuters · 4d ago
TEVA PHARMACEUTICAL INDUSTRIES LTD - EPYSQLI AVAILABLE AT 30% DISCOUNT TO SOLIRIS WAC
Reuters · 4d ago
Teva announces FDA acceptance of sBLA for AJOVY
TipRanks · 4d ago
Weekly Report: what happened at TEVA last week (0331-0404)?
Weekly Report · 4d ago
Arcutis Biotherapeutics: Zoryve's Growth Impresses, But Valuation Is A Concern (Rating Upgrade)
Seeking Alpha · 6d ago
Top Stock Reports for Cisco, Caterpillar & CME
NASDAQ · 04/03 20:35
India, China reciprocal tariffs will impact pharma, biotech industries
Seeking Alpha · 04/02 20:57
TCW Relative Value Mid Cap Fund Q4 2024 Commentary
Seeking Alpha · 04/02 17:06
Big Pharma drops sharply ahead of Trump’s tariff announcement
Seeking Alpha · 04/01 19:43
Positive Outlook for Teva Pharmaceuticals: Buy Rating Reiterated Amid Growth Initiatives and Improved Transparency
TipRanks · 04/01 12:15
Teva Highlights Phase 3 SOLARIS Trial Survey Results
Benzinga · 03/31 17:15
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
More
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.